Cryptococcal meningitis is the second-biggest killer of people living with HIV after tuberculosis. Now, a global initiative aims to get the gold-standard drug to treat cryptococcal meningitis, ...

Patients hospitalized with HIV and low CD4 counts should receive routine cryptococcal antigen testing, according to recent data presented at ECCMID 2015. Researchers reviewed the medical records of ...

The diagnosis of CM requires a high index of suspicion, particularly in sub-Saharan Africa, where there is a reduced standard of medical laboratory facilities and expertise. The role of detailed ...

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...

The IMMY CrAg® LFA (Cryptococcal Antigen Lateral Flow Assay) is the first and only immunochromatographic dipstick assay for the qualitative and semi-quantitative detection of the cryptococcal capsular ...

Cryptococcus neoformans commonly causes opportunistic infection in immunocompromised patients, especially in patients with AIDS. The CD4+ T-lymphocyte count is measured in patients with HIV infection, ...

A new, easier-to-administer and patient-friendly sustained-release formulation of flucytosine, a medicine used to treat cryptococcal meningitis, has entered Phase II clinical trials in Malawi and ...

Meningitis is an infection affecting the membranes that line the skull and spinal cord. Cryptococcal meningitis is a type of meningitis caused by a fungus called Cryptococcus. This type of meningitis ...

Meningitis is an infection and inflammation of the meninges, which are the membranes that cover the brain and spinal cord. Meningitis can be caused by different germs, including bacteria, fungi, and ...

Patients with solid organ transplants are at risk of invasive cryptococcal infection because of long-term immunosuppressive therapy. There has been a shift in the epidemiology of invasive cryptococcal ...

Hematopoietic stem cell transplantation (HSCT) can be lifesaving for some of the deadliest hematologic diseases. However, immunosuppression, polypharmacy and risk of infectious complications ...